167 related articles for article (PubMed ID: 20883163)
21. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; Parra-Cid T
World J Gastroenterol; 2009 Nov; 15(41):5129-40. PubMed ID: 19891011
[TBL] [Abstract][Full Text] [Related]
22. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.
Radziewicz H; Ibegbu CC; Fernandez ML; Workowski KA; Obideen K; Wehbi M; Hanson HL; Steinberg JP; Masopust D; Wherry EJ; Altman JD; Rouse BT; Freeman GJ; Ahmed R; Grakoui A
J Virol; 2007 Mar; 81(6):2545-53. PubMed ID: 17182670
[TBL] [Abstract][Full Text] [Related]
23. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR
J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749
[TBL] [Abstract][Full Text] [Related]
24. PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients.
Shen T; Zheng J; Xu C; Liu J; Zhang W; Lu F; Zhuang H
Virol J; 2010 Nov; 7():310. PubMed ID: 21070674
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
26. MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3.
Xu G; Yang F; Ding CL; Wang J; Zhao P; Wang W; Ren H
Virology; 2014 Aug; 462-463():343-50. PubMed ID: 25019494
[TBL] [Abstract][Full Text] [Related]
27. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.
Tomer S; Chawla YK; Duseja A; Arora SK
World J Gastroenterol; 2016 Jun; 22(22):5173-82. PubMed ID: 27298560
[TBL] [Abstract][Full Text] [Related]
28. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users.
Ye L; Wang X; Metzger DS; Riedel E; Montaner LJ; Ho W
PLoS One; 2010 Mar; 5(3):e9602. PubMed ID: 20231901
[TBL] [Abstract][Full Text] [Related]
30. Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways.
Steffensen MA; Fenger C; Christensen JE; Jørgensen CK; Bassi MR; Christensen JP; Finsen B; Thomsen AR
J Virol; 2014 Dec; 88(24):14090-104. PubMed ID: 25253351
[TBL] [Abstract][Full Text] [Related]
31. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
32. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients.
Shen T; Zheng J; Liang H; Xu C; Chen X; Zhang T; Xu Q; Lu F
Virol J; 2011 Jun; 8():279. PubMed ID: 21645420
[TBL] [Abstract][Full Text] [Related]
34. SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.
Yao ZQ; Waggoner SN; Cruise MW; Hall C; Xie X; Oldach DW; Hahn YS
J Virol; 2005 Dec; 79(24):15417-29. PubMed ID: 16306613
[TBL] [Abstract][Full Text] [Related]
35. HIV interferes with SOCS-1 and -3 expression levels driving immune activation.
Miller RC; Schlaepfer E; Baenziger S; Crameri R; Zeller S; Byland R; Audigé A; Nadal D; Speck RF
Eur J Immunol; 2011 Apr; 41(4):1058-69. PubMed ID: 21337543
[TBL] [Abstract][Full Text] [Related]
36. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
[TBL] [Abstract][Full Text] [Related]
37. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
Lukens JR; Cruise MW; Lassen MG; Hahn YS
J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
[TBL] [Abstract][Full Text] [Related]
38. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
[TBL] [Abstract][Full Text] [Related]
40. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
Kasprowicz V; Schulze Zur Wiesch J; Kuntzen T; Nolan BE; Longworth S; Berical A; Blum J; McMahon C; Reyor LL; Elias N; Kwok WW; McGovern BG; Freeman G; Chung RT; Klenerman P; Lewis-Ximenez L; Walker BD; Allen TM; Kim AY; Lauer GM
J Virol; 2008 Mar; 82(6):3154-60. PubMed ID: 18160439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]